Demulder A, Takahashi S, Singer F R, Hosking D J, Roodman G D
Veterans Administration Medical Center, San Antonio, Texas 78284.
Endocrinology. 1993 Nov;133(5):1978-82. doi: 10.1210/endo.133.5.7691583.
Paget's disease of bone is characterized by increased numbers of abnormal osteoclasts. To determine if osteoclast precursors were increased or abnormal in this disease, we examined CFU-GM, the committed granulocyte-macrophage progenitor and the most likely precursor for osteoclasts. In cultures of unfractionated marrow mononuclear cells, CFU-GM colony formation was significantly increased in Paget's marrow cultures compared to that in normal cells (356 +/- 44 vs. 271 +/- 15/10(5) cells; P < 0.05). However, when we enriched hematopoietic precursors from Paget's and normal marrow samples using an antibody that recognizes the CD34 antigen present on most hematopoietic precursors, we found that similar numbers of CFU-GM colonies were formed (87 +/- 13/10(4) cells plated vs. 83 +/- 13). Coculture experiments with highly purified hematopoietic precursors (CD34+ cells) and nonhematopoietic marrow accessory cells (CD34- cells) revealed that the growth of Paget's precursors was significantly enhanced above expected levels by normal or Pagetic CD34- cells (P < 0.05). CFU-GM colony formation was also significantly enhanced when normal CD34+ cells were cocultured with Pagetic, but not with normal, CD34- cells. In addition, CFU-GM colony-derived cells from Paget's patients were hyperresponsive to 1,25-dihydroxyvitamin D3 and could form osteoclast-like multinucleated cells with 1,25-dihydroxyvitamin D3 concentrations one tenth of that required for normal multinucleated formation (10(-11) vs. 10(-10) M). These data suggest that osteoclast precursors may be abnormal in Paget's disease, and other cells in the Pagetic marrow microenvironment may further enhance the growth and differentiation of these abnormal precursors.
骨佩吉特病的特征是异常破骨细胞数量增加。为了确定该疾病中破骨细胞前体细胞数量是否增加或异常,我们检测了CFU-GM,即定向粒细胞-巨噬细胞祖细胞,也是最有可能的破骨细胞前体细胞。在未分级的骨髓单个核细胞培养物中,与正常细胞相比,佩吉特骨髓培养物中的CFU-GM集落形成显著增加(356±44对271±15/10⁵个细胞;P<0.05)。然而,当我们使用识别大多数造血前体细胞上存在的CD34抗原的抗体从佩吉特和正常骨髓样本中富集造血前体细胞时,我们发现形成的CFU-GM集落数量相似(接种10⁴个细胞时为87±13对83±13)。用高度纯化的造血前体细胞(CD34⁺细胞)和非造血骨髓辅助细胞(CD34⁻细胞)进行的共培养实验表明,正常或佩吉特病的CD34⁻细胞使佩吉特病前体细胞的生长显著高于预期水平(P<0.05)。当正常CD34⁺细胞与佩吉特病的CD34⁻细胞而非正常的CD34⁻细胞共培养时,CFU-GM集落形成也显著增强。此外,来自佩吉特病患者的CFU-GM集落衍生细胞对1,25-二羟维生素D3反应过度,并且在1,25-二羟维生素D3浓度为正常多核形成所需浓度的十分之一时就能形成破骨细胞样多核细胞(10⁻¹¹对10⁻¹⁰M)。这些数据表明,佩吉特病中的破骨细胞前体细胞可能异常,并且佩吉特骨髓微环境中的其他细胞可能会进一步增强这些异常前体细胞的生长和分化。